Related Experiment Video
Updated: Apr 30, 2026
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The prognosis of primary percutaneous coronary intervention after one year clinical follow up
Yahya Dadjoo1, Yadallah Mahmoodi1
1Cardiovascular Research Center, Bagheiatallah University of Medical Sciences, Tehran, IR Iran.
Insights
Primary percutaneous coronary intervention (PCI) showed satisfactory one-year clinical outcomes. Most patients survived, with low rates of cardiac death and no major complications like reinfarction or stroke.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Percutaneous coronary intervention (PCI) is a key treatment for coronary artery disease.
- Evaluating long-term outcomes after primary PCI is crucial for patient management.
- Understanding risk factors and their impact on outcomes is essential.
Purpose of the Study:
- To assess the clinical outcomes one year after primary percutaneous coronary intervention (PCI).
- To identify factors influencing mortality and complications post-PCI.
Main Methods:
- A cohort of 70 patients undergoing primary PCI between September 2009 and March 2012 was analyzed.
- Treatments included drug-eluting stents, bare-metal stents, or balloon angioplasty.
- Clinical data and peri-interventional treatments were recorded for follow-up.
Main Results:
- The mean age was 61.34 years, with 72.9% males. High prevalence of diabetes (61.4%), hypertension (71.4%), and hyperlipidemia (52.9%).
- Overall one-year mortality was 4.3% (3 patients), with only 1.4% due to cardiac causes. No deaths within 30 days.
- No target vessel revascularization, reinfarction, mechanical complications, or strokes were observed. Mortality was higher in patients with hypertension and LAD ST-elevation myocardial infarction, but not statistically significant.
Conclusions:
- Primary PCI demonstrated a satisfactory one-year prognosis in the studied patient cohort.
- The study highlights the safety and efficacy of PCI in managing acute coronary syndromes.
- Further research may explore specific patient subgroups and long-term event rates.
Objectives:
The aim of this study was to evaluate the clinical outcomes, one year after primary percutaneous coronary intervention(PCI).
Patients And Methods:
From September 2009 to March 2012, primary PCI was performed on 70 cases, and the data relating to their catheterization were recorded. Peri-interventional treatment data included PCI with drug-eluting or bare-metal stent or balloon angioplasty alone.
Results:
The mean age of the patients was 61.34+11.31 years, and 72.9% of them were males. The ratios of patients with diabetes, hypertension and, hyperlipidemia were 61.4%, 71.4%, and 52.9% respectively. In clinical follow-up, total incidence of death was 4.3%, with no death occurring during 30 days. However, 3 patients died after one-year, of which one patient (1.4%) had cardiac problem and the other 2 (2.9%) died because of non-cardiac reasons. Target vessel revascularization, reinfarction within 30 days, and mechanical complication or stroke were not found in any of the patients. Patients with hypertension (6%) and those with LAD ST-elevation myocardial infarction (5%) died after one year (P= 0.263 and P= 0.319 respectively). However, no mortality was reported in patients with RCA and LCX ST-elevation myocardial infarction. Of subjects with multivessel disease, 7% died after one-year (P= 0.161), but there was no reported mortality in those with single vessel disease.
Conclusions:
The prognosis was satisfactory in patients undergoing PCI after one year clinical follow up.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:27Peripheral Artery Disease III: Interprofessional Care